86 related articles for article (PubMed ID: 37298089)
1. HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.
Khatkar P; Mensah G; Ning S; Cowen M; Kim Y; Williams A; Abulwerdi FA; Zhao Y; Zeng C; Le Grice SFJ; Kashanchi F
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256867
[TBL] [Abstract][Full Text] [Related]
2. Forced intercalation-induced light-up peptides as fluorogenic indicators for the HIV-1 TAR RNA-ligand assay.
Lee ETT; Sato Y; Ujuagu AF; Nishizawa S
Analyst; 2024 Jun; ():. PubMed ID: 38860915
[TBL] [Abstract][Full Text] [Related]
3. Development of FRET-based high-throughput screening for viral RNase III inhibitors.
Wang L; Saarela J; Poque S; Valkonen JPT
Mol Plant Pathol; 2020 Jul; 21(7):961-974. PubMed ID: 32436305
[TBL] [Abstract][Full Text] [Related]
4. High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble.
Ganser LR; Lee J; Rangadurai A; Merriman DK; Kelly ML; Kansal AD; Sathyamoorthy B; Al-Hashimi HM
Nat Struct Mol Biol; 2018 May; 25(5):425-434. PubMed ID: 29728655
[TBL] [Abstract][Full Text] [Related]
5. Development of a Time-Resolved Fluorescence Resonance Energy Transfer ultra-high throughput screening assay for targeting SYK and FCER1G interaction.
Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; ; Fu H
bioRxiv; 2024 Jun; ():. PubMed ID: 38915662
[TBL] [Abstract][Full Text] [Related]
6. HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin.
Muretta JM; Rajasekaran D; Blat Y; Little S; Myers M; Nair C; Burdekin B; Yuen SL; Jimenez N; Guhathakurta P; Wilson A; Thompson AR; Surti N; Connors D; Chase P; Harden D; Barbieri CM; Adam L; Thomas DD
SLAS Discov; 2023 Jul; 28(5):223-232. PubMed ID: 37307989
[TBL] [Abstract][Full Text] [Related]
7. KRAS4b:RAF-1 Homogenous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Drug Discovery.
Larsen EK; Abreu-Blanco M; Rabara D; Stephen AG
Methods Mol Biol; 2024; 2797():159-175. PubMed ID: 38570459
[TBL] [Abstract][Full Text] [Related]
8. Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening.
Kumar V; Chunchagatta Lakshman PK; Prasad TK; Manjunath K; Bairy S; Vasu AS; Ganavi B; Jasti S; Kamariah N
Heliyon; 2024 Jan; 10(1):e23864. PubMed ID: 38226204
[TBL] [Abstract][Full Text] [Related]
9. Molecule of the month: miRNA and HIV-1 TAR.
Shapshak P
Bioinformation; 2013; 9(2):65-6. PubMed ID: 23390347
[No Abstract] [Full Text] [Related]
10. Molecule of the month HIV-1 Tat and miRNA.
Shapshak P
Bioinformation; 2012; 8(23):1123-4. PubMed ID: 23275707
[No Abstract] [Full Text] [Related]
11. Small Molecules Targeting Viral RNA.
Mathez G; Cagno V
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686306
[TBL] [Abstract][Full Text] [Related]
12. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.
Hwang S; Tamilarasu N; Kibler K; Cao H; Ali A; Ping YH; Jeang KT; Rana TM
J Biol Chem; 2003 Oct; 278(40):39092-103. PubMed ID: 12857725
[TBL] [Abstract][Full Text] [Related]
14. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
15. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
16. A Novel Time-Resolved Fluorescence Resonance Energy Transfer Assay for the Discovery of Small-Molecule Inhibitors of HIV-1 Tat-Regulated Transcription.
Shin YH; Kim DE; Yu KL; Park CM; Kim HG; Kim KC; Bae S; Yoon CH
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298089
[TBL] [Abstract][Full Text] [Related]
17. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
